Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Dimai, HP; Muschitz, C; Amrein, K; Bauer, R; Cejka, D; Gasser, RW; Gruber, R; Haschka, J; Hasenöhrl, T; Kainberger, F; Kerschan-Schindl, K; Kocijan, R; König, J; Kroissenbrunner, N; Kuchler, U; Oberforcher, C; Ott, J; Pfeiler, G; Pietschmann, P; Puchwein, P; Schmidt-Ilsinger, A; Zwick, RH; Fahrleitner-Pammer, A.
Osteoporosis-Definition, risk assessment, diagnosis, prevention and treatment (update 2024): Guidelines of the Austrian Society for Bone and Mineral Research
WIEN KLIN WOCHENSCHR. 2024; 136(SUPPL 16): 599-668.
Doi: 10.1007/s00508-024-02441-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Dimai Hans Peter
- Co-Autor*innen der Med Uni Graz
- Amrein Karin
- Fahrleitner-Pammer Astrid
- Puchwein Paul
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Background Austria is among the countries with the highest incidence and prevalence of osteoporotic fractures worldwide. Guidelines for the prevention and management of osteoporosis were first published in 2010 under the auspices of the then Federation of Austrian Social Security Institutions and updated in 2017. The present comprehensively updated guidelines of the Austrian Society for Bone and Mineral Research are aimed at physicians of all specialties as well as decision makers and institutions in the Austrian healthcare system. The aim of these guidelines is to strengthen and improve the quality of medical care of patients with osteoporosis and osteoporotic fractures in Austria. Methods These evidence-based recommendations were compiled taking randomized controlled trials, systematic reviews and meta-analyses as well as European and international reference guidelines published before 1 June 2023 into consideration. The grading of recommendations used ("conditional" and "strong") are based on the strength of the evidence. The evidence levels used mutual conversions of SIGN (1++ to 3) to NOGG criteria (Ia to IV). Results The guidelines include all aspects associated with osteoporosis and osteoporotic fractures, such as secondary causes, prevention, diagnosis, estimation of the 10-year fracture risk using FRAX (R), determination of Austria-specific FRAX (R)-based intervention thresholds, drug-based and non-drug-based treatment options and treatment monitoring. Recommendations for the office-based setting and decision makers and institutions in the Austrian healthcare system consider structured care models and options for osteoporosis-specific screening. Conclusion The guidelines present comprehensive, evidence-based information and instructions for the treatment of osteoporosis. It is expected that the quality of medical care for patients with this clinical picture will be substantially improved at all levels of the Austrian healthcare system.
- Find related publications in this database (Keywords)
- Monitoring
- Osteoporotic fracture
- Fracture probability
- Intervention threshold
- Monitoring
- Osteoporotic fracture
- Fracture probability
- Intervention threshold
- FRAX